| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/08/2009 | EP2076128A2 Protein kinase inhibitors and methods for using thereof |
| 07/08/2009 | EP1776103B1 Ruthenium complexes for treating cancers |
| 07/08/2009 | EP1753744B1 Prodrugs of pyrrolylpyrimidine erk protein kinase inhibitors |
| 07/08/2009 | EP1735002B1 Cancer therapy comprising a nuclear receptor ligand and a hdac inhibitor |
| 07/08/2009 | EP1539933A4 Methods of organ regeneration |
| 07/08/2009 | EP1536808B1 Heterocarpin, a plant-derived protein with anti-cancer properties |
| 07/08/2009 | EP1536768B1 Biodegradable composition with prolonged release of an antitumour agent and preparation thereof |
| 07/08/2009 | EP1511740B1 Phenyl-thiophene type vitamin d receptor modulators |
| 07/08/2009 | EP1489169B1 Sumoylation inhibitors |
| 07/08/2009 | EP1435918B1 Highly compressible ethylcellulose for tableting |
| 07/08/2009 | EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene |
| 07/08/2009 | EP1073647B1 12,13-cyclopropane epothilone derivatives |
| 07/08/2009 | EP0669988B2 Angiogenesis inhibitory antibodies |
| 07/08/2009 | CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 07/08/2009 | CN101474398A Use of inhibitors for the treatment of disorders related to RTK hyperfunction |
| 07/08/2009 | CN100510073C Tryptase inhibitor |
| 07/08/2009 | CN100510060C Method of extended culture for antigen-specific cytotoxic t lymphocytes |
| 07/08/2009 | CN100509850C Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders |
| 07/08/2009 | CN100509846C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/08/2009 | CN100509843C Acid-modified arabinogalactan protein composition |
| 07/08/2009 | CN100509842C Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 07/08/2009 | CN100509836C Clone, expression and biological activity of stingray tumor suppressor gene |
| 07/08/2009 | CN100509811C Azaindoles |
| 07/08/2009 | CN100509810C Substituted beta-carbolines |
| 07/08/2009 | CN100509805C 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 07/08/2009 | CN100509790C Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
| 07/08/2009 | CN100509774C Acylsulfonamides as inhibitors of steroid sulfatase |
| 07/08/2009 | CN100509773C Alpha -amino-n-hydroxy-acetamide derivatives |
| 07/08/2009 | CN100509061C 改进的螯合剂缀合物 Improved chelator conjugate |
| 07/08/2009 | CN100509057C Antigen arrays for treatment of bone disease |
| 07/08/2009 | CN100509056C Vaccines including as an adjuvant type 1 IFN and process related thereto |
| 07/08/2009 | CN100509008C Shutongfang for killing pain and preparation and use thereof |
| 07/08/2009 | CN100508990C Acrochordon alleviation |
| 07/08/2009 | CN100508978C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 07/08/2009 | CN100508965C Dosage forms having prolonged active ingredient release |
| 07/08/2009 | CN100508961C Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapy, and the pharmaceutical use thereof |
| 07/08/2009 | CN100508954C Preparation process and prescription of oleum fructus bruceae containing microemulsion |
| 07/07/2009 | USRE40839 Taxol treatment of cancer |
| 07/07/2009 | US7557222 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors Xa and VIIa for the treatment of thrombosis |
| 07/07/2009 | US7557204 CUDR as biomarker for cancer progression and therapeutic response |
| 07/07/2009 | US7557187 Polypeptide; an amino acid sequence of the family of tumour-suppressing genes related to the gene for the p53 protein; isolated nucleic acid sequences coding for the proteins |
| 07/07/2009 | US7557140 e.g. 3-[3-(2,4-Difluoro-phenylsulfamoyl)-phenyl]-N-hydroxy-acrylamide; histone deacetylase inhibitor; anticarcinogenic, antiinflammatory agent, autoimmune diseases; leukemia, atheriosclerosis, Alzheimer's disease, rheumatoid arthritis, psoriasis |
| 07/07/2009 | US7557129 Cyanopyridine derivatives useful in the treatment of cancer and other disorders |
| 07/07/2009 | US7557118 4-Phenyl-6H-(1)Benzopyrano(4',3':4,5)pyrrolo(2,1-a)isoquinolin-6-one's and analogues, optionally mixed with acceptable carriers, excipients or diluents, used for treating multidrug resistant tumors, for inducing apoptosis and as immunology modulators |
| 07/07/2009 | US7557113 5-{2-[(t-butoxy)carbonylamino]ethyl}-6-{3-chloro(2-thienyl)}-4-oxo-3-hydr- opyrrolo[3,2-d]pyrimidin-7-carboxyamide; GSK-3 inhibitor; diabetes, diabetic complications, Alzheimer's, neurodegenerative, manic depression, traumatic cerebrospinal injury, alopecia, inflammatory diseases, cancer, immunodeficienc |
| 07/07/2009 | US7557110 Pyrazolo[1,5-A] pyrimidine derivatives |
| 07/07/2009 | US7557107 tricyclic compounds such as 4-{8-Chloro-6-[[(1-methoxy-cyclopropanecarbonyl)-amino]-(3-methyl-3H-imidazol-4- yl)-methyl]-11H-benzo[5.6]cyclohepta[1,2-b]pyridin-11-yl}-piperazine-1-carboxylic acid isopropyl ester, used as enzyme inhibitors for treatment of cancers |
| 07/07/2009 | US7557106 inhibitors of FLT-3, Aurora-1, Aurora-2, and Aurora-3 protein kinases; leukemia; N-{4-[4-(5-Methyl-2H-pyrazol-3-ylmethyl)-6-(4-propyl-piperazin-1-yl)-pyrim- idin-2-ylsulfanyl]-phenyl}-propionamide |
| 07/07/2009 | US7557105 Proliferative disorders; cancer; 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide |
| 07/07/2009 | US7557096 stilbene phosphate derivatives; anticarcinogenic agents; bactericide, fungicide; veterinary medicine |
| 07/07/2009 | US7556957 Attenuated virus-like particle for use as gene transfer tool in treatment and prevention of metabolic disorders; tissue target therapy |
| 07/07/2009 | US7556827 Implantable active ingredient depot comprising matrix of glyceryl-monooleate and at least one modifier molecule comprising 1,2-distearoyl-glycerophosphatidyl-ethanolamin-methyl-polyethylene glycol wherein matrix provides controlled release of active ingredient |
| 07/07/2009 | US7556803 Using kappa-myeloma antigen specific immunoglobulins to target and destroy tumor cells; immunotherapy |
| 07/07/2009 | CA2518195C Antitumor effect potentiator and antitumor agent |
| 07/07/2009 | CA2486101C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 07/07/2009 | CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 07/07/2009 | CA2405892C Substituted caprolactam carbonates and ethers and their use as anti-tumor agents |
| 07/07/2009 | CA2400994C Radioactive therapeutic liposomes |
| 07/07/2009 | CA2345353C Null igf for the treatment of cancer |
| 07/07/2009 | CA2201161C Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 07/07/2009 | CA2167692C Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 07/02/2009 | WO2009082687A1 Azaindolizines and methods of use |
| 07/02/2009 | WO2009082662A1 Combination of nilotinib and a nitrogen mustard analogue for the treatment of chronic lymphocytic leukemia |
| 07/02/2009 | WO2009082641A2 Compositions and methods for treating diseases associated with angiogenesis and inflammation |
| 07/02/2009 | WO2009082526A2 Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation |
| 07/02/2009 | WO2009081789A1 Sulfonyl substituted 6-membered ring derivative |
| 07/02/2009 | WO2009081366A1 Palladium and platinum phosphine complexes and their use as anti-tumour agents |
| 07/02/2009 | WO2009081349A1 5-phenyl-lh-benz0 [e] [1, 4] diazepine compounds substituted with an hydroxamic acid group as histone deacetylase inhibitors |
| 07/02/2009 | WO2009081275A2 Antifolate compounds for the treatment of melanoma |
| 07/02/2009 | WO2009081197A1 Bicyclic derivatives for use in the treatment of androgen receptor associated conditions |
| 07/02/2009 | WO2009081105A2 Quinoxaline and quinoline derivatives as kinase inhibitors |
| 07/02/2009 | WO2009080898A2 Products and methods for preventing tumour growth |
| 07/02/2009 | WO2009080853A1 Cis bicyclic complexes of platinum (ii) having anticancer activity |
| 07/02/2009 | WO2009080850A1 Method for increasing the therapeutic efficacy of curcuminoids and analogues |
| 07/02/2009 | WO2009080837A1 Medicament for the treatment of cancer of the pancreas |
| 07/02/2009 | WO2009080835A1 Thyromimetric compounds in treatment of disease related to sonic hedgehog signalling |
| 07/02/2009 | WO2009080832A1 Methods and agents for improving targeting of cd138 expressing tumor cells |
| 07/02/2009 | WO2009080831A1 Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates |
| 07/02/2009 | WO2009080830A1 Immunoconjugates targeting cd138 and uses thereof |
| 07/02/2009 | WO2009080829A1 Agents targeting cd138 and uses thereof |
| 07/02/2009 | WO2009080810A1 New polypeptides having affinity for her2 |
| 07/02/2009 | WO2009080753A1 Pm-2 antibodies and methods for treating metastasis |
| 07/02/2009 | WO2009080722A2 Carboxylic derivatives for use in the treatment of cancer |
| 07/02/2009 | WO2009080705A2 Bis-thiazole derivatives, process for their preparation and their use as medicaments |
| 07/02/2009 | WO2009080694A1 Thiazole derivatives used as pi 3 kinase inhibitors |
| 07/02/2009 | WO2009080675A1 Quinoline derivatives with affinity for the 5-ht2b receptor |
| 07/02/2009 | WO2009080523A1 Substituted hydantoins as mek kinase inhibitors |
| 07/02/2009 | WO2009080488A1 Spiroindolinone derivatives as anticancer agents |
| 07/02/2009 | WO2009080482A1 Pharmaceutical compositions comprising octahedral metal (iii) polypyridyl complexes and their use in prevention and treatment of cancer |
| 07/02/2009 | WO2009080366A1 A process of making imatinib |
| 07/02/2009 | WO2009080314A1 Pyridazine derivatives useful as fungicides and for the treatment of cancer |
| 07/02/2009 | WO2009080200A1 Novel sulphoximide-substituted quinoline and quinazoline derivatives as kinase inhibitors |
| 07/02/2009 | WO2009079922A1 Humanized anti-cd34 monoclonal antibody, the preparation and uses thereof |
| 07/02/2009 | WO2009079911A1 Pegylated erythropoietin conjugate and preparation method and uses thereof |
| 07/02/2009 | WO2009079878A1 Injection comprising docetaxel and its preparation |
| 07/02/2009 | WO2009079797A1 Compounds and method for treatment of cancer |
| 07/02/2009 | WO2009079790A1 Polypeptide-nucleic acid conjugates and uses thereof |
| 07/02/2009 | WO2009079768A1 Methods of inhibiting tumor growth using ttk antagonists |
| 07/02/2009 | WO2009079767A1 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer |
| 07/02/2009 | WO2009079692A1 Halogenated analogues of anti-fibrotic agents |